Dechra Pharmaceuticals PLC Director/PDMR Shareholding (4638T)

TIDMDPH

RNS Number : 4638T

Dechra Pharmaceuticals PLC

12 October 2017

12 October 2017

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Grant of SAYE options:

Dechra Pharmaceuticals PLC announces that today the following PDMRs were granted options over ordinary shares of 1p each in the Company pursuant to the Dechra Pharmaceuticals Save As You Earn Scheme (the Options).

The Options have been granted with an exercise price of GBP16.46.

 
 Name              Capacity    Options Granted 
 Ian Page          Director    1,093 
 Richard Cotton    Director    1,093 
 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  -------------------------------------------------------------- 
 a)   Name                           Ian Page 
---  -----------------------------  ------------------------------- 
 2.   Reason for the notification 
---  -------------------------------------------------------------- 
 a)   Position/status                Director/PDMR 
---  -----------------------------  ------------------------------- 
 b)   Initial notification/          Initial Notification 
       amendment 
---  -----------------------------  ------------------------------- 
 3.   Details of the Issuer 
---  -------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ------------------------------- 
 b)   LEI code                       213800J4UVB5OWG8VX82 
---  -----------------------------  ------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------------------- 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument 
 
       Identification                 ISIN: GB0009633180 
       code 
---  -----------------------------  ------------------------------- 
 b)   Nature of                      Grant of 1,093 options under 
       the transaction                the Company's Save As You 
                                      Earn Scheme 
---  -----------------------------  ------------------------------- 
 c)   Price(s) and                   Price(s)         Volume(s) 
       volumes(s) 
                                      GBP16.46         1,093 
---  -----------------------------  ---------------  -------------- 
 d)        Aggregated 
            information 
             *    Aggregate volume     1,093 
                                       GBP17,990.78 
 
             *    Price 
---  -----------------------------  ------------------------------- 
 e)   Date of the                    2017.10.12 
       transaction 
---  -----------------------------  ------------------------------- 
 f)   Place of the                   Outside a trading venue 
       transaction 
---  -----------------------------  ------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  -------------------------------------------------------------- 
 a)   Name                           Richard Cotton 
---  -----------------------------  ------------------------------- 
 2.   Reason for the notification 
---  -------------------------------------------------------------- 
 a)   Position/status                Director/PDMR 
---  -----------------------------  ------------------------------- 
 b)   Initial notification/          Initial Notification 
       amendment 
---  -----------------------------  ------------------------------- 
 3.   Details of the Issuer 
---  -------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ------------------------------- 
 b)   LEI code                       213800J4UVB5OWG8VX82 
---  -----------------------------  ------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------------------- 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument 
 
       Identification                 ISIN: GB0009633180 
       code 
---  -----------------------------  ------------------------------- 
 b)   Nature of                      Grant of 1,093 options under 
       the transaction                the Company's Save As You 
                                      Earn Scheme 
---  -----------------------------  ------------------------------- 
 c)   Price(s) and                   Price(s)         Volume(s) 
       volumes(s) 
                                      GBP16.46         1,093 
---  -----------------------------  ---------------  -------------- 
 d)        Aggregated 
            information 
             *    Aggregate volume     1,093 
                                       GBP17,990.78 
 
             *    Price 
---  -----------------------------  ------------------------------- 
 e)   Date of the                    2017.10.12 
       transaction 
---  -----------------------------  ------------------------------- 
 f)   Place of the                   Outside a trading venue 
       transaction 
---  -----------------------------  ------------------------------- 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKBDDDBDDQKD

(END) Dow Jones Newswires

October 12, 2017 07:15 ET (11:15 GMT)